BioCentury | Jan 21, 2021
Management Tracks

MacDonald to succeed retiring Ostrach as Dynavax CFO; plus Antibiotic Resistance UK, Arix, Viridian, Avrobio, Imago, ONL, Atea, Chiasma, Tiziana, Elevar,  and Imara

...VP of medical affairs. The U.S. and South Korea-based cancer company changed its name from LSK...
BioCentury | Jun 28, 2019
Clinical News

June 28 Clinical Quick Takes: Imfinzi extends survival in Phase III SCLC study; plus LSK, Pfizer, FibroGen, Aclaris and more

...bladder cancer and non-small cell lung cancer (NSCLC). Rivoceranib misses in gastric cancer Phase III LSK...
...a second-line therapy for gastric cancer, as well as other clinical trials for other cancers. LSK...
...rigerimod (CEP-33457, ipp-201101, P140, syb l-1001, forigerimod) Pamrevlumab (FG-3019) Revatio, Viagra, sildenafil FibroGen Inc. ImmuPharma plc Jiangsu Hengrui Medicine Co. Ltd. LSK...
BioCentury | Mar 15, 2017
Clinical News

Apatinib: Ph III ANGEL started

...lines of standard chemotherapy. BSC is defined as palliative non-cancer therapy at the investigator’s discretion. LSK...
...of China from Advenchen Laboratories. Jiangsu Hengrui markets the product in China for gastric cancer. LSK...
...Pharma to develop and market the product in Korea. Advenchen Laboratories LLC , Moorpark, Calif. LSK...
BioCentury | Sep 21, 2015
Company News

University of Utah, LSK BioPharma deal

...The Huntsman Cancer Institute at the university granted LSK exclusive, worldwide rights to develop and commercialize...
...The partners declined to disclose financial terms. University of Utah , Salt Lake City, Utah LSK...
BioCentury | Jun 17, 2013
Company News

Life Technologies, LSK deal

...Life Technologies acquired South Korean distribution partner LSK. Life Technologies said the acquisition was "in line...
...Life Technologies said the acquisition was "in line with our go-direct strategy in South Korea." LSK...
...PCR products. The companies did not disclose additional terms. Life Technologies Corp. (NASDAQ:LIFE), Carlsbad, Calif. Life Science Korea (LSK)...
BioCentury | Jul 11, 2011
Regulation

Looking beyond Avastin

...II GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) Tyverb/Tykerb lapatinib HER1 and HER2 receptor kinase inhibitor Ph II LSK...
Items per page:
1 - 6 of 6
BioCentury | Jan 21, 2021
Management Tracks

MacDonald to succeed retiring Ostrach as Dynavax CFO; plus Antibiotic Resistance UK, Arix, Viridian, Avrobio, Imago, ONL, Atea, Chiasma, Tiziana, Elevar,  and Imara

...VP of medical affairs. The U.S. and South Korea-based cancer company changed its name from LSK...
BioCentury | Jun 28, 2019
Clinical News

June 28 Clinical Quick Takes: Imfinzi extends survival in Phase III SCLC study; plus LSK, Pfizer, FibroGen, Aclaris and more

...bladder cancer and non-small cell lung cancer (NSCLC). Rivoceranib misses in gastric cancer Phase III LSK...
...a second-line therapy for gastric cancer, as well as other clinical trials for other cancers. LSK...
...rigerimod (CEP-33457, ipp-201101, P140, syb l-1001, forigerimod) Pamrevlumab (FG-3019) Revatio, Viagra, sildenafil FibroGen Inc. ImmuPharma plc Jiangsu Hengrui Medicine Co. Ltd. LSK...
BioCentury | Mar 15, 2017
Clinical News

Apatinib: Ph III ANGEL started

...lines of standard chemotherapy. BSC is defined as palliative non-cancer therapy at the investigator’s discretion. LSK...
...of China from Advenchen Laboratories. Jiangsu Hengrui markets the product in China for gastric cancer. LSK...
...Pharma to develop and market the product in Korea. Advenchen Laboratories LLC , Moorpark, Calif. LSK...
BioCentury | Sep 21, 2015
Company News

University of Utah, LSK BioPharma deal

...The Huntsman Cancer Institute at the university granted LSK exclusive, worldwide rights to develop and commercialize...
...The partners declined to disclose financial terms. University of Utah , Salt Lake City, Utah LSK...
BioCentury | Jun 17, 2013
Company News

Life Technologies, LSK deal

...Life Technologies acquired South Korean distribution partner LSK. Life Technologies said the acquisition was "in line...
...Life Technologies said the acquisition was "in line with our go-direct strategy in South Korea." LSK...
...PCR products. The companies did not disclose additional terms. Life Technologies Corp. (NASDAQ:LIFE), Carlsbad, Calif. Life Science Korea (LSK)...
BioCentury | Jul 11, 2011
Regulation

Looking beyond Avastin

...II GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) Tyverb/Tykerb lapatinib HER1 and HER2 receptor kinase inhibitor Ph II LSK...
Items per page:
1 - 6 of 6